# A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-3b-randomized-double-blind-placebo-controlled-study-of-sodium-zirconium/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Steven Fishbane,Martin L. Ford,Masafumi Fukagawa,Kieran McCafferty,Anjay Rastogi,Bruce Spinowitz,Konstantin Staroselskiy,Konstantin Vishnevskiy,Vera Lisovskaja,Ayman Al‐Shurbaji,Nicolás Guzmán,Sunil Bhandari |
| Citations | 148 |
| DOI | 10.1681/asn.2019050450 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jasn.asnjournals.org/content/jnephrol/30/9/1723.full.pdf |
| OpenAlex ID | https://openalex.org/W2949981799 |
| PMID | 31201218 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Anjay Rastogi](https://scholariq.org/researchers/anjay-rastogi/)
- [Kieran McCafferty](https://scholariq.org/researchers/kieran-mccafferty/)

## Paper journal

- [Journal of the American Society of Nephrology](https://scholariq.org/journals/journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)

## Paper topics

- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.